Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | EIF3J |
| Upstream (Parents) |
|---|
| (<<) PLUNC → EIF3J |
| (<<) RAPGEF4 → EIF3J |
| (<<) PTCH1 → EIF3J |
| (<<) TBC1D30 → EIF3J |
| (<<) ANKRD12 → EIF3J |
| (<<) PPIL2 → EIF3J |
| (<<) HMGB3L1 → EIF3J |
| (<<) ZNF643 → EIF3J |
| (<<) LILRA6 → EIF3J |
| (<<) ZNF473 → EIF3J |
| (<<) LETM1 → EIF3J |
| Downstream (Children) |
|---|
| EIF3J → SCGB1A1 (>>) |
| EIF3J → CSH2 (>>) |
| EIF3J → RPAIN (>>) |
| EIF3J → PLUNC (>>) |
| EIF3J → RFPL3S (>>) |
| EIF3J → LOC440345 (>>) |
| EIF3J → OR1E2///OR1E1 (>>) |
| EIF3J → CNOT3 (>>) |
| EIF3J → PTCH1 (>>) |
| EIF3J → TMLHE (>>) |
| EIF3J → TBC1D30 (>>) |
| EIF3J → FAM169A (>>) |
| EIF3J → ANKRD12 (>>) |
| EIF3J → PGLYRP1 (>>) |
| EIF3J → ADH7 (>>) |
| EIF3J → SH3D19///RUNX1 (>>) |
| EIF3J → TRAF3IP2 (>>) |
| EIF3J → CTNS (>>) |
| EIF3J → HMGB3L1 (>>) |
| EIF3J → HOXA3 (>>) |
| EIF3J → AAAS (>>) |
| EIF3J → TMEM19 (>>) |
| EIF3J → E2F4 (>>) |
| EIF3J → RPL5P1///RPL5P34///RPL5 (>>) |
| EIF3J → ENTPD4 (>>) |
| EIF3J → ZNF473 (>>) |
| EIF3J → LETM1 (>>) |
